Nevertheless, a significant proportion of melanoma cases (44.9% according to Greaves et al. [32]) harbor BRAF mutations, the most frequent of which is the T1799A transversion, resulting in a valine-to-glutamic acid substitution (V600E) in the protein. This evidence concerns the gene BRAF and melanoma.